These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26135851)

  • 1. Chitosan-coated red fluorescent protein nanoparticle as a potential dual-functional siRNA carrier.
    Liu Y; Song ZM; Deng X; Cui Y; Yang YF; Han K; Jin R; Wang H; Liu Y; Cao A
    Nanomedicine (Lond); 2015; 10(13):2005-16. PubMed ID: 26135851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
    Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
    J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
    Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
    J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo.
    Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K
    J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
    Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
    J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
    Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma.
    Labala S; Jose A; Venuganti VV
    Colloids Surf B Biointerfaces; 2016 Oct; 146():188-97. PubMed ID: 27318964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
    Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
    Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
    Lu HD; Zhao HQ; Wang K; Lv LL
    Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line.
    Fernández Fernández E; Santos-Carballal B; Weber WM; Goycoolea FM
    Int J Pharm; 2016 Apr; 502(1-2):1-9. PubMed ID: 26875537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.
    Fernandes JC; Qiu X; Winnik FM; Benderdour M; Zhang X; Dai K; Shi Q
    Int J Nanomedicine; 2012; 7():5833-45. PubMed ID: 23209368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.